RELVAR™ ELLIPTA™ Gains Approval in Japan for the Treatment of Asthma (via MarketWired)SOURCE: Theravance, Inc. September 20, 2013 03:00 ET LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA--(Marketwired - Sep 20, 2013) - GlaxoSmithKline plc (LSE: GSK) (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the Japanese…
0 comments:
Post a Comment